Source high-purity Beinaglutide, a novel long-acting GLP-1 receptor agonist peptide designed for advanced metabolic research. This innovative fusion protein offers extended half-life and potent glucose-dependent insulin secretion, making it ideal for studying type 2 diabetes mechanisms and obesity pathways. Perfect for laboratories investigating incretin therapy and metabolic regulation. High-quality raw material. Get a quote today!